1. Home
  2. RGNX vs KPLT Comparison

RGNX vs KPLT Comparison

Compare RGNX & KPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo REGENXBIO Inc.

RGNX

REGENXBIO Inc.

N/A

Current Price

$7.26

Market Cap

487.2M

Sector

Health Care

ML Signal

N/A

Logo Katapult Holdings Inc.

KPLT

Katapult Holdings Inc.

N/A

Current Price

$9.40

Market Cap

392.0M

ML Signal

N/A

Company Overview

Basic Information
Metric
RGNX
KPLT
Founded
2008
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Diversified Commercial Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
487.2M
392.0M
IPO Year
2015
2019

Fundamental Metrics

Financial Performance
Metric
RGNX
KPLT
Price
$7.26
$9.40
Analyst Decision
Strong Buy
Buy
Analyst Count
11
2
Target Price
★ $21.40
$12.00
AVG Volume (30 Days)
★ 1.1M
388.2K
Earning Date
11-05-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
18.08
★ 98.15
EPS
N/A
★ 0.83
Revenue
$10,393,000.00
★ $291,761,000.00
Revenue This Year
N/A
$130.18
Revenue Next Year
$24.01
$0.95
P/E Ratio
★ N/A
$11.79
Revenue Growth
★ 126.48
18.03
52 Week Low
$5.46
$3.85
52 Week High
$16.19
$12.68

Technical Indicators

Market Signals
Indicator
RGNX
KPLT
Relative Strength Index (RSI) 44.73 51.14
Support Level $6.79 $6.26
Resistance Level $7.32 $12.32
Average True Range (ATR) 0.59 1.42
MACD -0.03 -0.25
Stochastic Oscillator 15.40 39.76

Price Performance

Historical Comparison
RGNX
KPLT

About RGNX REGENXBIO Inc.

Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.

About KPLT Katapult Holdings Inc.

Katapult Holdings Inc. is a technology-driven lease-to-own platform that integrates with omni-channel retailers and e-commerce platforms to power the purchase of everyday durable goods for underserved U.S. non-prime consumers. It is an e-commerce-focused FinTech company offering a lease-purchase solution to consumers and enabling essential transactions at the merchant point of sale. Katapult is associated with hundreds of retailers across the United States.

Share on Social Networks: